Clinical, oncological, and prognostic differences of patients with subsequent skeletal-related events in bone metastases

This study found that 17% of patients required treatments for a second, subsequent SRE, and the current clinical guideline did not provide a specific approach to this clinical condition. We observed that referencing the initial treatment, patients in the subsequent SRE group had longer six-week, 90-day, and one-year median survival than patients in the single SRE group. Once patients develop a subsequent SRE, they have a worse one-year survival rate than those who receive treatment for a single SRE. Future research should identify prognostic factors and assess the applicability of existing survival prediction models for better management of subsequent SREs.

Authors

Institutions

Publication Details

Journal
Bone and Joint Research
Published
2024-09-16
DOI
https://doi.org/10.1302/2046-3758.139.bjr-2023-0372.r1
Citations
5
Primary Topic
Management of metastatic bone disease
Type
article
Field-Weighted Citation Impact
2.86

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Clinical, oncological, and prognostic differences of patients with subsequent skeletal-related events in bone metastases

Ming‐Hsiao Hu, Stein J. Janssen, Hung‐Kuan Yen, Hsiang‐Chieh Hsieh et al.
5 citations
Bone and Joint Research
Management of metastatic bone disease
2.86
article

Clinical, oncological, and prognostic differences of patients with subsequent skeletal-related events in bone metastases

Ming‐Hsiao Hu, Stein J. Janssen, Hung‐Kuan Yen, Hsiang‐Chieh Hsieh, Fu‐Shan Jaw, Wei‐Hsin Lin, Olivier Q. Groot, Ching-Wei Lin, Yuting Pan, Wen-Tung Hsieh
article en
5 citations

Abstract

This study found that 17% of patients required treatments for a second, subsequent SRE, and the current clinical guideline did not provide a specific approach to this clinical condition. We observed that referencing the initial treatment, patients in the subsequent SRE group had longer six-week, 90-day, and one-year median survival than patients in the single SRE group. Once patients develop a subsequent SRE, they have a worse one-year survival rate than those who receive treatment for a single SRE. Future research should identify prognostic factors and assess the applicability of existing survival prediction models for better management of subsequent SREs.

Bone and Joint ResearchVol. 13(9)
National Taiwan University (TW), University Medical Center Utrecht (NL), Chang Gung Memorial Hospital (TW), Massachusetts General Hospital (US), National Taiwan University Hospital (TW), Amsterdam University Medical Centers (NL)
National Taiwan University Hospital, National Taiwan University
Good health and well-being
Openalex Percentile: Top 9%
Management of metastatic bone disease
2.86
DOIOpen Access PDFOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Clinical, oncological, and prognostic differences of patients with subsequent skeletal-related events in bone metastases — Ming‐Hsiao Hu, Stein J. Janssen, et al. · Bone and Joint Research (2024) | TGRS Research Map | TGRS